SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Pharmaceuticals, Inc. Launches Combivent® Respimat® (Ipratropium Bromide and Albuterol) Inhalation Spray for Chronic Obstructive Pulmonary Disease